Q9RLM5 AF NFT

Type II nicking enzyme V.NmeDIP

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiavthbj5ffmladbeem3cfhnlcvvpwjacuuik6t3c23m2uzhq5ue3m/metadata.json
IPFS of structure file: 
bafybeibwmx4cjj47qlmui77z6jg5nlddj3mnskiaxohjy4t473gaynz7xm/AF-Q9RLM5-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x7EAF4972fBCA2131d603a72C142a37eC45Edd45A
First NFT owner address (bech32): 
genesis106h5juhmegsnr4sr5ukpg23ha3z7m4z64frpwd
Current NFT ID #498307 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
498307
Accession (UniProt):
Q9RLM5
Name::
Type II nicking enzyme V.NmeDIP
Experimental Method:
Predicted structure
Sequence source:
NEISSERIA MENINGITIDIS SEROGROUP C

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9RLM5 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9RLM5|VSN1_NEIMC Type II nicking enzyme V.NmeDIP OS=Neisseria meningitidis serogroup C OX=135720 GN=vsr PE=3 SV=1 MDRLTPEQRKKCMQSNKSKGTKPELALAKAMWALGLRYRKNSGSIFGKPDFSFKKYKVAVFVDGEFWHGKDWEQRKAEIKGNREFWIAKIERNIRRDMEVTGRLKVEGWAVLRFWSNDVVKNTTCCAEKVRQAVRDKQGLSKFQTREK